PD-1 and PD-L1 expression in cardiac transplantation

被引:11
|
作者
Bishawi, Muath [1 ,2 ]
Bowles, Dawn [1 ]
Pla, Michelle Mendiola [1 ]
Oakes, Faye [3 ]
Chiang, Yuting [1 ]
Schroder, Jacob [1 ]
Milano, Carmelo [1 ]
Glass, Carolyn [4 ,5 ]
机构
[1] Duke Univ, Dept Surg, Durham, NC USA
[2] Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA
[3] Duke Sch Med, Durham, NC USA
[4] Duke Univ, Dept Pathol, Durham, NC 27706 USA
[5] Duke Univ, Duke Transplant Ctr, Durham, NC USA
关键词
cardiac transplantation; PD-Ll; PD-1; rejection; B7; FAMILY; MEMBER;
D O I
10.1016/j.carpath.2021.107331
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Programmed death-ligand 1 (PD-L1), a transmembrane protein and member of the CD28 T cell family is associated with lymphocyte activation) PD-L1 expression is upregulated on activated antigen presenting cells such as monocytes, myeloid and dendritic cells.(2) When bound to its cognate receptor programmed cell death (PD-1), inhibition of immune responses including downregulation of T cell proliferation occurs.(3) Mechanistically, such inhibition would be hypothetically favorable in the setting of a transplanted organ undergoing allograft rejection. However, there is a paucity of data addressing the role of PD-L1 and PD-1 expression in the human transplanted heart. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    [J]. BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [2] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [3] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    [J]. ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [4] Expression of PD-L1 and PD-1 in Cutaneous Warts
    Yu, Wesley
    Berger, Timothy
    Laszik, G. Zoltan
    North, Jeffrey
    Cohen, Jarish
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [5] PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Fiegl, H.
    Marth, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 64 - 64
  • [6] PD-1 and PD-L1 expression in ovarian cancer
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Reimer, D.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [7] Expression of PD-L1 and PD-1 in conjunctival melanoma
    Cao, Jinfeng
    Richards, Kate
    Jordanova, Ekaterina S.
    Arinkovic, Marina
    Hurkmans, Daan
    van Duinen, Sjoerd G.
    van der Velden, Pieter A.
    Jager, Martine J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Expression of PD-L1 and PD-1 in Cutaneous Warts
    Yu, Wesley
    Berger, Timothy
    Laszik, G. Zoltan
    North, Jeffrey
    Cohen, Jarish
    [J]. MODERN PATHOLOGY, 2019, 32
  • [9] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    [J]. ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [10] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38